JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Phreesia
PHR
$689M
| $13.7M | ﹤0.01% |
443,070
+22,315
| +5% | +$699K |
|
1952
Ironwood Pharmaceuticals
IRWD
$586M
| $13.7M | ﹤0.01% |
1,290,421
+655,313
| +103% | +$7.04M |
|
1953
United Bankshares
UBSI
$6.69B
| $13.7M | ﹤0.01% |
462,117
+618
| +0.1% | +$19.5K |
|
1954
PUT
Viking Therapeutics
VKTX
$3.88B
| $13.7M | ﹤0.01% |
+844,500
| New | +$17.7M |
|
1955
PUT
Lowe's Companies
LOW
$121B
| $13.7M | ﹤0.01% |
60,600
-118,600
| -66% | -$24.7M |
|
1956
Avis
CAR
$5.47B
| $13.7M | ﹤0.01% |
59,798
-29,609
| -33% | -$5.43M |
|
1957
iShares US Medical Devices ETF
IHI
$3.17B
| $13.7M | ﹤0.01% |
242,005
-45,214
| -16% | -$2.49M |
|
1958
Duolingo
DUOL
$6.53B
| $13.7M | ﹤0.01% |
95,548
-22,439
| -19% | -$3.22M |
|
1959
PVH
PVH
$4.07B
| $13.6M | ﹤0.01% |
160,602
-24,142
| -13% | -$2.04M |
|
1960
Vanguard Consumer Staples ETF
VDC
$8.16B
| $13.6M | ﹤0.01% |
70,156
+4,385
| +7% | +$857K |
|
1961
Piper Sandler
PIPR
$4.99B
| $13.5M | ﹤0.01% |
418,876
+62,864
| +18% | +$2.08M |
|
1962
Invesco MSCI Sustainable Future ETF
ERTH
$131M
| $13.5M | ﹤0.01% |
276,105
-112,223
| -29% | -$5.33M |
|
1963
FNB Corp
FNB
$6.76B
| $13.5M | ﹤0.01% |
1,181,660
-236,827
| -17% | -$2.68M |
|
1964
CALL
Baidu
BIDU
$35.7B
| $13.5M | ﹤0.01% |
98,600
+98,200
| +24,550% | +$12.9M |
|
1965
Hess Midstream
HESM
$5.19B
| $13.4M | ﹤0.01% |
437,436
+344,546
| +371% | +$9.94M |
|
|
KRTX
1966
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $13.4M | ﹤0.01% |
61,743
+9,086
| +17% | +$1.95M |
|
|
SEE
1967
DELISTED
Sealed Air
SEE
| $13.4M | ﹤0.01% |
334,715
+72,714
| +28% | +$3.09M |
|
1968
PUT
Johnson & Johnson
JNJ
$640B
| $13.4M | ﹤0.01% |
80,800
-113,700
| -58% | -$18.4M |
|
1969
PUT
Chubb
CB
$140B
| $13.4M | ﹤0.01% |
69,400
-11,100
| -14% | -$2.17M |
|
1970
Upbound Group
UPBD
$1.22B
| $13.4M | ﹤0.01% |
429,255
-3,924
| -0.9% | -$115K |
|
1971
WisdomTree US MidCap Dividend Fund
DON
$4.05B
| $13.3M | ﹤0.01% |
317,245
-226
| -0.1% | -$9.17K |
|
1972
Adeia
ADEA
$2.55B
| $13.3M | ﹤0.01% |
1,209,101
+407,816
| +51% | +$3.72M |
|
1973
Gibraltar Industries
ROCK
$1.28B
| $13.3M | ﹤0.01% |
211,537
-24,030
| -10% | -$1.3M |
|
1974
Dorian LPG
LPG
$1.96B
| $13.3M | ﹤0.01% |
518,395
+138,368
| +36% | +$3.14M |
|
1975
Beyond Meat
BYND
$274M
| $13.3M | ﹤0.01% |
1,022,133
+909,780
| +810% | +$11.6M |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.